NCT01751178

Brief Summary

The aim of this study is to compare subject gingival health after 6 weeks of twice daily use of a non-alcohol or alcohol containing mouthrinse and brushing compared to brushing only.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
324

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Oct 2012

Shorter than P25 for phase_4

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 13, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 17, 2012

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

July 28, 2014

Completed
Last Updated

July 28, 2014

Status Verified

June 1, 2014

Enrollment Period

5 months

First QC Date

December 13, 2012

Results QC Date

May 1, 2014

Last Update Submit

July 3, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Gingival Severity Index (GSI) Based on the Gingival Index (GI)

    Measure of gingival severity averaged across whole mouth site; each site scored 0, 1, 2, 3 based on GI and, 1. GSI = 0 if GI is 0 or 1 (no bleeding) 2. GSI = 1 if GI is 1 or 2 (bleeding)

    Change from baseline to 6 weeks

Secondary Outcomes (3)

  • Gingival Index

    Change from baseline to 6 weeks

  • Turesky Modification of Quigley & Hein Plaque Index for Overall Plaque Scores

    Change from baseline to 6 weeks

  • Turesky Modification of Quigley & Hein Plaque Index for Interproximal Plaque Scores

    Change from baseline to 6 weeks

Study Arms (2)

Mouthwash with Alcohol

ACTIVE COMPARATOR

rinse with 10ml 0.2% w/v Chlorhexidine Digluconate Mouthwash with alcohol for 1 timed minute twice daily for 6 weeks following brushing with a full brush head of standard toothpaste for 1 timed minute.

Drug: Chlorhexidine Digluconate Mouthwash with Alcohol

Mouthwash without Alcohol

ACTIVE COMPARATOR

rinse with 10ml 0.2% w/v Chlorhexidine Digluconate Mouthwash without alcohol for 1 timed minute twice daily for 6 weeks following brushing with a full brush head of standard toothpaste for 1 timed minute.

Drug: Chlorhexidine Digluconate Mouthwash without Alcohol

Interventions

0.2% w/v Chlorhexidine Digluconate, alcohol containing - UK Marketed Mouthwash

Mouthwash with Alcohol

0.2% w/v Chlorhexidine Digluconate, without alcohol - UK Marketed Mouthwash

Mouthwash without Alcohol

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Good general health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history or oral/ dental examination.
  • \. a) Good oral health in the opinion of the investigator (allowing mild to moderate gingivitis to meet entry criteria).
  • b) A minimum of 20 permanent gradable teeth at screening. (Gradable teeth are those where restorative materials cover less than 25% of the tooth surface graded).
  • c) Mild to moderate gingivitis present at the screening visit in the opinion of the investigator.
  • d) Positive response to bleeding on brushing exercise at screening visit. e) A total of 20 bleeding sites or greater at baseline visit.

You may not qualify if:

  • Known or suspected intolerance or hypersensitivity to Chlorhexidine or other study materials (or closely related compounds) or any of their stated ingredients.
  • \. a) Current or relevant history of any serious, severe or unstable physical or psychiatric illness or any other medical condition (e.g. Diabetes Mellitus) that would make the subject unlikely to fully complete the study or any that increases the risk to the subject or undermines the data validity.
  • b) Subjects requiring prophylactic antibiotic treatment prior to dental therapy.
  • c) Use of concomitant medication that, in the opinion of the investigator, might interfere with the outcome of the study or increases the risk to the subject (eg: phenytoin, calcium antagonists, cyclosporine, warfarin, antibiotics, immuno-suppressants).
  • d) Use of antibiotics within two weeks prior to the screening visit or throughout the study.
  • e) Use of any systemic medication which would have an effect on gingival conditions within 14 days of gingival examinations (eg: ibuprofen or aspirin therapy) 6. a) Have current active caries b) More than 3 pockets with 5mm or over. c) Excessive calculus present that interferes with the probing examination for Gingival Index.
  • d) Other severe oral/ gingival conditions (e.g. Acute Necrotizing Ulcerative Gingivitis) that may compromise the study or the subjects in the opinion of the investigator or gingivitis examiner.
  • e) Medical conditions which may directly influence gingival bleeding. f) Restorations in a poor state of repair. g) Orthodontic appliances anterior cosmetic restorations and veneers. h) Enamel pitting/irregularities. 7. Subjects using chewing tobacco, pan, pan-masala, gutkha or other chewing tobacco products or subjects who have quit using any of those within the past six months prior to screening.
  • \. b) An employee of any toothpaste manufacturer or their immediate family.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Intertek 4-Front Research - Widnes

Widnes, Cheshire, WA8 6PG, United Kingdom

Location

4Front, Ellesmere Port

Cheshire, CH65 4BW, United Kingdom

Location

Intertek - Manchester Science Park

Manchester, M15 6SE, United Kingdom

Location

MeSH Terms

Conditions

Gingivitis

Interventions

Ethanol

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Results Point of Contact

Title
GSK Response Center
Organization
GlaxoSmithKline

Study Officials

  • GSK Clinical Trials

    GlaxoSmithKline

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2012

First Posted

December 17, 2012

Study Start

October 1, 2012

Primary Completion

March 1, 2013

Study Completion

March 1, 2013

Last Updated

July 28, 2014

Results First Posted

July 28, 2014

Record last verified: 2014-06

Locations